Combat SRD, with Increxxa’s tulathromycin

77

Balancing whole herd health with individual pig solutions. Combat swine respiratory disease (SRD) with Increxxa ®’s industry-proven molecule, tulathromycin. Increxxa is indicated for the treatment of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, and Mycoplasma hyopneumoniae; and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.